Vazirani Asset Management’s Amedisys AMED Stock Holding History

Vazirani Asset Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,450	Closed	-$733K	–	15
2025 Q2	$733K	Sell	7,450 -50	-0.7%	-$4.73K	2.8%	11
2025 Q1	$695K	Sell	7,500 -2,500	-25%	-$230K	2.56%	9
2024 Q4	$908K	Buy	+10,000	New	+$918K	2.82%	8
2024 Q3	–	Sell	-20,000	Closed	-$1.84M	–	31
2024 Q2	$1.84M	Buy	+20,000	New	+$1.86M	3.91%	9
2023 Q4	–	Sell	-35,000	Closed	-$3.27M	–	23
2023 Q3	$3.27M	Buy	+35,000	New	+$3.23M	5%	7

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vazirani Asset Management's AMED Position: Q3 2025 in Review

Vazirani Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 7,450 shares — an estimated $733K sold.

Vazirani Asset Management first reported a position in AMED in Q3 2023 and held it in 5 quarters. The position peaked at $3.27M in Q3 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Vazirani Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Vazirani Asset Management sold 7,450 Amedisys shares in Q3 2025, an estimated $733K.
Vazirani Asset Management first reported a position in Amedisys in Q3 2023 and held it in 5 quarters.
Vazirani Asset Management's Amedisys position peaked at $3.27M in Q3 2023.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Vazirani Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.